HEALTH OF WOMAN. 2020.9-10(155-156): 28-32; doi 10.15574/HW.2020.155-156.28
Tatarchuk T. F.¹, Dunaevskaya V. V.^1,2, Kosei N. V.^3
1SI «Institute of Pediatrics, Obstetrics and Gynecology of the National Academy of Medical Sciences of Ukraine», Kyiv
²National Cancer Institute, Kyiv
³SSI «Center for Innovative Medical Technologies of the National Academy of Sciences of Ukraine», Kyiv

Continuing increase of precancer, epithelial and invasive vulvar cancer rate significantly enlarges the proportion of this group of patients. Meanwhile, all the grounds to improve the system of early diagnosis and treatment of this pathology are given nowadays. No other localization of gynecological cancer proves such a close association with postmenopause and involute atrophic processes of this period of a woman’s life.
The objective: is to study the features of the clinical course of cancer and precancerous lesions of the vulva in women of reproductive age.
Materials and methods. From 2017 to 2020, 150 patients with dystrophic diseases, precancerous lesions and vulvar cancer were examined in the outpatient department of the National Cancer Institute. The age of patients in the study ranged from 18 to 49 years old (32±3.5). Menstrual function was unchanged in 98 (65%) of 150 women. The age of menarche varied from 11 to 18 years old (mean age – 14.5±0.3 years). The average duration of the menstrual cycle was 28±0.4 days.
The doctor performed conservative treatment of «leukoplakia and kraurosis» for many months, and sometimes years, without histological clarification of the diagnosis. More than half (n=106; 71%) of patients underwent long-term and unreasonable anti-inflammatory or hormonal therapy with unsatisfactory results without cytological and / or histological examinations.
Results. In the study of vulvar biopsies, the VIN diagnosis (28%) prevailed in comparison with the invasive tumor process (12%) and was asymptomatic in more than 50% of cases. Thus, the peak level of HPV was observed in young women (80%). HPV was represented by types of high oncogenic risk (16, 18, 31, 33) in 90% of cases and it was associated with a malignant process in 100% of cases.
At the same time, the background disease in young patients is squamous cell hyperplasia, where the sequence of tumor development (VIN I – VIN II – VIN III) is more clearly traced and largely resembles the development of cervical cancer. It has been noted that in young women PVI is usually temporary, there is a faster spontaneous elimination of the virus and regression of existing HPV-associated pathology compared with menopausal women.
Conclusion. Vulvar neoplasia is more common in the VIN form in women of reproductive age and in all cases, it is associated with human papillomavirus (HPV) of high oncogenic risk. Multicentric lesions are more typical for young patients.
Keywords: vulva, cancer, precancer, anamnesis, vulvoscopy, histological examination.

REFERENCES

1. Bokhman YaV. 2002. Kerivnytstvo po onkoekolohii. SPb, Foliant:542.

2. Zharov AV, Vazhenin AV. 2005. Optymizatsiia likuvannia khvorykh na rak vulvy. Cheliabinsk, Typohrafiia ChTZ:132.

3. Kaprin AD, Starinskyi VV, Petrova HV. 2016. Stan onkolohichnoho dohliadu naselennia Rosii v 2015 r. M.

4. Petrova HV, Kaprin AD, Hretsova OP, Starinskyi VV. 2015. Zloiakisni pukhlyny v Rosii. M.

5. Manukhin IB, Kondrikov NI, Kraposhyna TP. 2002. Zakhvoriuvannia zovnishnikh statevykh orhaniv: kerivnytstvo dlia likariv. M, MIA:302.

6. Ashrafian LA, Kharchenko NV, Kiselov VI, Sveshnikov PH i dr. 2006. Rak vulvy: etiopatohenetychna kontseptsiia. M, Moloda gvardiia:192.

7. Kaufman R, Faro S, Braun D. 2009. Dobroiakisni zakhvoriuvannia vulvy i pikhvy. Per. s anhl. M, Binom:548.

8. de Witte CJ, van de Sande AJ, van Beekhuizen HJ, Koeneman MM et al. 2015, Nov. Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review. Gynecol. Oncol. 139;2:377–384. https://doi.org/10.1016/j.ygyno.2015.08.018; PMid:26335596

9. Ashrafian LA, Kiselov VI. 2008. Pukhlyny reproduktyvnyh organiv (etiologiia ta patohenez). M, Dimitreid Hrafik Hrup:208.

10. Khashuko AZ, Otdelna OB, Kupeieva ES. 2012. Fotodynamichna terapiia dystrofichnykh zakhvoriuvan vulvy v poiednanni z infektsiieiu papilomy/likuvannia i profilaktyka 4:78–80.

11. Uilkinson YeDzh, Stoun KI. 2009. Khvoroba vulvy. Klinichne kerivnytstvo. Per. z anhl. M, Binom:248.

12. Del Pino M, Rodriguez-Carunchio L, Ordi J. 2013. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma. Histopathology. 62;1:161-175. https://doi.org/10.1111/his.12034; PMid:23190170

13. Foster DC. 2002. Vulvar disease. Obstet. Gynecol. 100;1:145-163. https://doi.org/10.1016/S0029-7844(02)02080-X

14. Disai FDzh, Krisman UT. 2011. Klinichna onkoekologiia. Per. z anhl. M, Rid Эlsiver. 1:316.

15. Urmancheieva AF, Tiuliandin SA, Moiseienko VM. 2008. Praktychna onkoekologiia: vybrani lektsii. SPb, Tsentr TOMM:400.

16. Stehman FB, Look KY. 2006. Carcinoma of the vulva. Obstet.Gynecol. 107;3:719-733. https://doi.org/10.1097/01.AOG.0000202404.55215.72; PMid:16507947

17. Chovanec J, Moukova L, Feranec R. 2013. Preinvasive lesions in gynecology – vulva. Klin. Onkol. 26;Suppl:S44-S46. https://doi.org/10.14735/amko2013S44; PMid:24325163

18. ACOG Committee Opinion No. 509: Management of vulvar intraepithelial neoplasia. Obstet. Gynecol. 2011, Nov. 118;5:1192-1194. https://doi.org/10.1097/AOG.0b013e31823b17c2; PMid:22015906

19. Cherenkov VH, Oleksandrova IV, Shpenkova AA. 2010. Rak vulvy: patohenetychni varianty, diahnostyka, likuvannia, plastychna khirurhiia/pukhlyny zhinochoi reproduktyvnoi systemy 4:78-85.

20. Wallbillich JJ, Rhodes HE, Milbourne AM. 2012. Vulvar intraepithelial neoplasia (VIN 2/3): comparing clinical outcomes and evaluating risk factors for recurrence. Gynecol. Oncol. 127;2:312-315. https://doi.org/10.1016/j.ygyno.2012.07.118; PMid:22867736 PMCid:PMC3632361

21. Chulkova OV, Novikova EH, Sokolov VV, Chulkova EA. 2006. Diahnostyka i likuvannia fonu i peredrakovyh zakhvoriuvan vulvy/praktychna onkologiia 7;4:197–204.

22. Yutaka U, Takayuki E, Toshihiro K. 2011. Two distinct pathways to development of squamous cell carcinoma of the vulva. J.Skin Cancer. – P. 34–41. Article ID 951250.

23. Reauer S. 2004. Vulvar lichen sclerosus. The importance of early clinical and histological diagnosis. Hautartz. 55;2:158-164. https://doi.org/10.1007/s00105-003-0645-8; PMid:14968326

24. Siegler E, Segev Y, Mackuli L, Auslender R et al. 2016, May. Vulvar and vaginal cancer, vulvar intraepithelial neoplasia 3 and vaginal intraepithelial neoplasia 3: Experience of a Referral Institute. Isr. Med. Assoc. J. 18;5:286-289.

25. Van de Nieuwenhof HP. 2010. Lichen Sclerosus and Vulvar Intraepithelial Neoplasia in Vulvar Cancer. Veghel.: 412-418.

26. Apolykhina IA. 2002. Papilomovirusna infektsiia henitalii u zhinok. M, HЭOTAR-MED:112.

27. Van de Nieuwenhof HP, van Kempen LCLT, de Hullu JA. 2009. The etiologic role of HPV in vulvar squamous cell carcinoma fi ne tuned. Cancer Epidemiol. Biomarkers Prev. 18;7:2061-2067. https://doi.org/10.1158/1055-9965.EPI-09-0209; PMid:19567503

28. Nelson EL, Bogliatto F, Stockdale CK. 2015. Vulvar intraepithelial neoplasia (VIN) and condylomata. Clin. Obstet. Gynecol. 58;3:512-525. https://doi.org/10.1097/GRF.0000000000000132; PMid:26133495